South Korea Bans Novartis Drugs Over Kickbacks

Source: Reuters

Mar 03, 2017

South Korea's Ministry of Food and Drug Safety has fined Novartis $174,937 and temporarily banned sales of some of its drugs for paying kickbacks to doctors.

The ministry placed a fine on 30 drug items and banned sales of 12 variations of 3 drug types including Alzheimer's drug Exelon for three months, reported Reuters. The sales ban will be effective from March 17 through June 16.

Read the Reuters article

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments